Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study

Simple item page
dc.contributor.authorChubb, P.
dc.contributor.authorHyde, Z.
dc.contributor.authorAlmeida, O.
dc.contributor.authorFlicker, L.
dc.contributor.authorNorman, P.
dc.contributor.authorJamrozik, K.
dc.contributor.authorHankey, G.
dc.contributor.authorYeap, B.
dc.date.issued2008
dc.description.abstract<h4>Background</h4>Reduced circulating testosterone and sex hormone-binding globulin (SHBG) are implicated as risk factors for metabolic syndrome. As SHBG increases with age while testosterone declines, we examined the relative contributions of SHBG and testosterone to the risk of metabolic syndrome in older men.<h4>Methods</h4>We conducted a cross-sectional study of 2502 community-dwelling men aged > or = 70 years without known diabetes. Metabolic syndrome was defined using the National Cholesterol Education Program-Third Adult Treatment Panel (NCEP-ATPIII) criteria. Early morning fasting sera were assayed for total testosterone, SHBG and LH. Free testosterone was calculated using mass action equations.<h4>Results</h4>There were 602 men with metabolic syndrome (24.1%). The risk of metabolic syndrome increased for total testosterone < 20 nmol/l, SHBG < 50 nmol/l and free testosterone < 300 pmol/l. In univariate analyses SHBG was associated with all five components of metabolic syndrome, total testosterone was associated with all except hypertension, and free testosterone was associated only with waist circumference and triglycerides. In multivariate analysis, both total testosterone and especially SHBG remained associated with metabolic syndrome, with odds ratios of 1.34 (95% confidence interval (CI): 1.18-1.52) and 1.77 (95% CI: 1.53-2.06) respectively. Men with hypogonadotrophic hypogonadism (total testosterone < 8 nmol/l, LH < or = 12 IU/l) had the highest prevalence of metabolic syndrome (53%, P<0.001).<h4>Conclusions</h4>Lower SHBG is more strongly associated with metabolic syndrome than lower total testosterone in community-dwelling older men. SHBG may be the primary driver of these relationships, possibly reflecting its relationship with insulin sensitivity. Further studies should examine whether measures that raise SHBG protect against the development of metabolic syndrome in older men.
dc.description.statementofresponsibilityS A Paul Chubb, Zoë Hyde, Osvaldo P Almeida, Leon Flicker, Paul E Norman, Konrad Jamrozik, Graeme J Hankey and Bu B Yeap
dc.identifier.citationEuropean Journal of Endocrinology (EJE), 2008; 158(6):785-792
dc.identifier.doi10.1530/EJE-07-0893
dc.identifier.issn0804-4643
dc.identifier.issn1479-683X
dc.identifier.urihttp://hdl.handle.net/2440/46809
dc.language.isoen
dc.publisherBio Scientifica Ltd
dc.rights© 2008 by European Society of Endocrinology
dc.source.urihttps://doi.org/10.1530/eje-07-0893
dc.subjectHumans
dc.subjectTestosterone
dc.subjectSex Hormone-Binding Globulin
dc.subjectMultivariate Analysis
dc.subjectRisk Factors
dc.subjectFollow-Up Studies
dc.subjectProspective Studies
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectAustralia
dc.subjectMale
dc.subjectMetabolic Syndrome
dc.titleLower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

General Practice publications